Evaluation of Ablation Index and VISITAG™ (ABI-173)

Clinical trial NCT03062046 · COMPLETED

Trial details

NCT number: NCT03062046
Sponsor: Biosense Webster, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Paroxysmal Atrial Fibrillation

Start date: 2017-01-27
Primary completion: 2019-03-27
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.